Red blood cell concentrate is the highest-demanded blood product in North American healthcare. Donated red blood cells are an extremely precious resource and there is currently no way to test for blood quality without breaching the sterility of the blood bag. Other than a visual inspection, most available techniques are destructive and require sampling of the bag. In a study recently…
Read More
A new data centre at Simon Fraser University will bring together researchers to better understand and combat drug-resistant superbugs. The university officially opened the new Canadian Statistical Sciences Institute, or Canssi, headquarters at the Burnaby campus on Friday. The Canssi headquarters, at SFU’s Big Data Hub, is described by university staff as a “statistical and data science powerhouse” for researchers studying everything from climate…
Read More

Grizzly Bear Genome Sequenced for the First Time by Scientists at the GSC

Among the largest predators in the country, the Grizzly bear now has another claim to fame: the most complete genetic map for its species. Within 37 pairs of chromosomes composed of about 2.3 billion nucleotide base pairs, scientists have now revealed the location of 19,848 coding genes, 7,061 non-coding genes, 3,671 pseudo-genes, and more, within the Grizzly genome. The Grizzly…
Read More
The federal government is phasing out a 30-year-old funding program known for connecting teams of scientists across Canada and encouraging them to work together in key areas of biomedical and environmental research, The Globe and Mail has learned. On Thursday, Science Minister Kirsty Duncan is expected to reveal that the government will eventually discontinue supporting the entities that are collectively…
Read More
Scientists have long studied brain tissue in a search for the functional changes to the brain that accompany psychiatric disease. But the complexity of the brain presents challenges: the brain is made up of dozens of different types of cells. If researchers could inspect each cell type individually, they could gain greater insight into how the brain changes with psychiatric…
Read More
Somewhere in Canada, 24 people have gone through a frightening experience caused by the simple act of eating romaine lettuce. It happened sometime in late October or early November, when they unknowingly ingested a dangerous pathogen — E. coli O157:H7 — hiding in the lettuce leaves. Days later they began to feel symptoms, possibly a headache or a mild fever. They could have developed…
Read More
MSFHR is implementing gender neutral peer review processes for all 2019 competitions, starting with the 2019 Research Trainee (now open for applications) and 2019 Scholar (LOI passed) competitions. As BC’s health research funding agency, with a specific focus on talent development, we think deeply about how to grow, improve and best support BC health research and researchers. We use our Program Learning…
Read More
The prevalence of Canadians living with Crohn’s disease is growing at a rapid rate. While there are currently 135,000 Canadians living with inflammatory bowel disease, that number is expected to rise by 50 percent by the year 2030. Currently Crohn’s is considered an autoimmune disease, meaning the immune system goes awry, attacking and inflaming the body’s own intestinal lining. Treatment…
Read More
The European Commission and the Canadian Institutes of Health Research have announced more than $12 million in funding to expand SFU’s iReceptor initiative. iReceptor is a newly developed platform for managing massive repositories of worldwide distributed data that researchers can securely access in their quest to develop new therapies for autoimmune and infectious diseases, and cancer. Felix Breden, iReceptor’s scientific…
Read More
AbCellera announced today its collaboration with Autolus Therapeutics plc (Autolus), a clinical stage biopharmaceutical company developing next-generation programmed T cell therapies. Under the partnership, AbCellera is applying its microfluidic single-cell screening platform to find novel antibodies which can be used for the development of new Chimeric Antigen Receptor (CAR) T cell therapies. CARs are engineered targeting molecules comprised of a…
Read More